NORTHLEAF-CAPITAL
Northleaf Capital Partners (Northleaf) is pleased to announce the appointment of Chris O’Connor as Managing Director, Business Development, Australia and New Zealand. In this new role, Chris will lead Northleaf’s business development and investor relations activities and further develop relationships with institutional investors, consultants and advisors in the region. Chris joins Northleaf’s existing Melbourne-based investment team, extending the firm’s ongoing commitment to private markets activities in Australia and New Zealand.
“We are thrilled to welcome Chris to the Northleaf team as our first Australia-based business development executive,” said Jeff Pentland, Managing Director and Head of Business Development at Northleaf. “Chris brings expertise in both relationship building and consultative fundraising, enhancing our capabilities to provide investors with access to highly differentiated mid-market infrastructure, private equity and private credit investments globally.”
Prior to joining Northleaf, Chris was Managing Director, Business Development at Queensland Investment Corporation where he managed client and prospect relationships with institutional investors and asset consultants, covering the fund’s alternative asset class offerings. Previously, Chris was Head of Sales, Asia Pacific at Eze Software (now part of SS&C) in Sydney where he progressed from Vice President, Head of European Sales in London to launch the firm’s first Australian office and build out the Australian client base.
“I am excited to continue to develop Northleaf’s presence in Australia, and to execute the firm’s focused client servicing strategy,” said Chris. “This is a unique opportunity to join a leading institutional asset manager with a compelling growth strategy and to enhance Northleaf’s position worldwide.”
Northleaf recently announced the final closing for its third OECD-focused infrastructure fund at US$1.4 billion, exceeding its original target fund size. Northleaf also held the final closing for its second closed-end private credit fund and a separately managed account, raising more than US$900 million to invest in performing loans to global mid-market companies. With recent fundraising across its three core private markets strategies (infrastructure, private credit and private equity), Northleaf has now raised more than US$17 billion in capital commitments and serves more than 150 institutional investors globally. Northleaf is currently raising capital for the next generation of its global private equity and certain of its private credit funds.
About Northleaf Capital Partners
Northleaf Capital Partners is a global private markets investment firm with more than US$17 billion in private equity, private credit and infrastructure commitments under management on behalf of public, corporate and multi-employer pension plans, endowments, foundations, financial institutions and family offices. Northleaf’s 150-person team, located in Toronto, Chicago, London, Melbourne, Menlo Park, Montreal and New York, is focused exclusively on sourcing, evaluating and managing private markets investments globally. Northleaf’s portfolio includes more than 400 active investments in 40 countries, with a focus on mid-market companies and assets. For more information on Northleaf, please visit www.northleafcapital.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210804006185/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Canva Launches Creative Operating System30.10.2025 18:00:00 CET | Press release
Next era of Canva combines a supercharged Visual Suite, world-first design AI, and powerful tools to grow your brand Canva Design Model: World-first AI model that understands complexities and ingredients of design. AI Where You Work: Bring your imagination to life in every part of the design process, plus, a new design assistant. Video 2.0: A reimagined video editor makes professional and engaging content effortless. Canva Grow: Powerful marketing engine to ideate, create, distribute, and refine engaging ads to scale your brand. All-New Affinity: All-in-one app built by pro designers for pro designers, now forever free. Forms: Design interactive forms that can be added to any design for everything from RSVP forms to contact pages. Email Design: Design engaging emails with Canva’s drag-and-drop editor, then export to your platform of choice. Canva Code in Sheets: Seamlessly link interactive widgets with Canva Sheets to bring data to life in real time. Canva, the world’s only all-in-one
Svante Celebrates 18 Years of Carbon Management Innovation with Historic Milestones in 202530.10.2025 17:25:00 CET | Press release
Svante Technologies Inc. (Svante), a global leader in carbon capture and removal solutions, proudly marks its 18th anniversary this month, celebrating nearly two decades of pioneering industrial carbon management technology. This year has been one of the most transformative in Svante’s history, defined by bold innovation, strategic partnerships, and the commissioning of the world’s first commercial manufacturing facility for solid sorbent-based carbon capture and removal filters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030974500/en/ Founded in 2007 with a vision to revolutionize how the world manages carbon dioxide emissions, Svante has grown into a cornerstone of the global carbon management industry. In 2025, that vision took a monumental leap forward with the launch of the Redwood Facility in Burnaby, BC — a 141,000-square-foot Centre of Excellence for Carbon Capture and Removal. This first-of-its-kind manufactu
Ireland Unveils Seven New Halloween Experiences30.10.2025 15:00:00 CET | Press release
More celebrations than ever across the island of Ireland – the true Home of Halloween With seven brand-new Halloween hubs or experiences launching across the island this month, Ireland has truly become the ultimate destination to celebrate Halloween in 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251022209535/en/ Derry Halloween Festival, County Derry~Londonderry Ireland’s Halloween Season Rooted in the ancient Celtic festival of Samhain, Halloween originated in Ireland more than 2,000 years ago and, this year, the island of Ireland is expanding its celebration like never before. With over 340 events planned across the island to celebrate this year, Halloween in Ireland is fast becoming a bucket-list travel experience. Seven new Halloween hubs join existing flagship events across the island of Ireland including the Púca Festival in County Meath and Derry Halloween in Derry-Londonderry which together welcomed over 169
Staloral® Birch Phase III Study Successfully Meets Primary Endpoint, Demonstrating Efficacy in Children and Adolescents30.10.2025 14:56:00 CET | Press release
Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of Staloral® Birch in children and adolescents with birch pollen-induced allergic rhino-conjunctivitis (ARC), with or without asthma, has successfully achieved its primary endpoint. The trial enrolled 553 children aged 5 -17 years with moderate to severe birch pollen-induced ARC, with or without asthma, across 64 sites in 12 European countries and assessed the efficacy and safety of Staloral® birch 300IR daily maintenance dose administered pre-and co-seasonally over two consecutive birch pollen seasons. The YOBI study successfully met its primary endpoint, demonstrating the efficacy of Staloral® Birch in a paediatric population (5-17) with a 41% improvement in the ARC total combined score during the second pollen season compared to placebo. These results were highly statistically significant
Debiopharm Forges AI-powered Alliance With NetTargets to Pioneer Dual-payload ADCs Against Drug-resistant Cancers30.10.2025 14:00:00 CET | Press release
An Alliance to Combat Resistance: Debiopharm and NetTargets will collaborate to develop next-generation, dual-payload Antibody-Drug Conjugates (ADCs) designed to overcome acquired resistance mechanisms in difficult-to-treat cancers. AI-Powered Precision: The collaboration combines NetTargets' proprietary AI discovery platform—to identify synergistic drug pairings—with Debiopharm’s MLINK Duo technology for coordinated delivery of two distinct warheads on a single ADC. Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based, biopharmaceutical company dedicated to developing innovative therapies that respond to high unmet medical needs, today announced a strategic research collaboration with NetTargets (www.net-targets.com), a South Korean biotech company specializing in AI-enhanced systems biology for drug discovery, to rationally design and advance the discovery of novel, synergistic drug combinations for Debiopharm’s next-generation Antibody-Drug Conjugates (ADCs). This allianc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
